Optimal Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.97M Buy
29,040
+88
+0.3% +$11.1K 0.5% 64
2021
Q2
$3.09M Hold
28,952
0.37% 97
2021
Q1
$2.6M Buy
28,952
+11,200
+63% +$1.05M 0.34% 109
2020
Q4
$1.64M Sell
17,752
-28
-0.2% -$2.5K 0.23% 149
2020
Q3
$1.83M Buy
17,780
+3,756
+27% +$392K 0.27% 130
2020
Q2
$1.42M Sell
14,024
-6,836
-33% -$612K 0.23% 146
2020
Q1
$1.4K Buy
20,860
+14,688
+238% +$914K 0.13% 239
2019
Q4
$338K Buy
+6,172
New +$293K 0.05% 359

Other funds holding DXCM

Optimal Asset Management's DXCM Position: Q3 2021 in Review

Optimal Asset Management increased its DexCom (DXCM) stake by 0.3% in Q3 2021, buying an estimated $11.1K and bringing the position to 29,040 shares worth $3.97M. The position accounts for 0.5% of the portfolio, ranked #64.

Optimal Asset Management first reported a position in DXCM in Q4 2019 and has held it in 8 quarters since. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2021.

  • Optimal Asset Management held 29,040 shares of DexCom worth $3.97M as of Q3 2021.
  • Optimal Asset Management bought 88 DexCom shares in Q3 2021, an estimated $11.1K.
  • DexCom made up 0.5% of Optimal Asset Management's portfolio in Q3 2021, its #64 holding.
  • Optimal Asset Management first reported a position in DexCom in Q4 2019 and has held it in 8 quarters since.
  • 795 funds tracked by Wall St. Rank held DexCom as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.